Kenneth Krogulski - Dec 1, 2022 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Director
Signature
Kenneth J. Krogulski by /s/ John Hamm as attorney-in-fact
Stock symbol
CPIX
Transactions as of
Dec 1, 2022
Transactions value $
$6,778
Form type
4
Date filed
12/23/2022, 04:07 PM
Previous filing
Dec 23, 2022
Next filing
Mar 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Purchase $245 +105 +0.05% $2.33 202K Dec 1, 2022 Direct F1
transaction CPIX Common Stock Purchase $243 +105 +0.05% $2.31 202K Dec 2, 2022 Direct F1
transaction CPIX Common Stock Purchase $230 +105 +0.05% $2.19 202K Dec 5, 2022 Direct F1
transaction CPIX Common Stock Purchase $230 +105 +0.05% $2.19 202K Dec 6, 2022 Direct F1
transaction CPIX Common Stock Purchase $229 +105 +0.05% $2.18 202K Dec 7, 2022 Direct F1
transaction CPIX Common Stock Purchase $230 +105 +0.05% $2.19 203K Dec 8, 2022 Direct F1
transaction CPIX Common Stock Purchase $226 +105 +0.05% $2.15 203K Dec 9, 2022 Direct F1
transaction CPIX Common Stock Purchase $225 +105 +0.05% $2.14 203K Dec 12, 2022 Direct F1
transaction CPIX Common Stock Purchase $698 +320 +0.16% $2.18 203K Dec 13, 2022 Direct F1
transaction CPIX Common Stock Purchase $707 +320 +0.16% $2.21 203K Dec 14, 2022 Direct F1
transaction CPIX Common Stock Purchase $323 +144 +0.07% $2.24 204K Dec 15, 2022 Direct F1
transaction CPIX Common Stock Purchase $546 +246 +0.12% $2.22 204K Dec 16, 2022 Direct F1
transaction CPIX Common Stock Purchase $995 +450 +0.22% $2.21 204K Dec 19, 2022 Direct F1
transaction CPIX Common Stock Purchase $855 +370 +0.18% $2.31 205K Dec 20, 2022 Direct F1
transaction CPIX Common Stock Purchase $799 +360 +0.18% $2.22 205K Dec 21, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.